News | Cardiovascular Business | February 11, 2019

Medical Bills Financially Burden Almost Half of Cardiovascular Disease Patients

Study finds many insured and uninsured patients must pay bills over time or cannot pay at all

Medical Bills Financially Burden Almost Half of Cardiovascular Disease Patients

February 11, 2019 — Over 45 percent of adult atherosclerotic cardiovascular disease (ASCVD) patients suffer financial hardship related to their medical bills, according to a new cardiovascular medicine and society paper. The paper, published in the Journal of the American College of Cardiology, notes that many of these patients cannot pay their medical bills at all.

ASCVD is the leading cause of death in the United States and the disease with the highest healthcare costs for a single class of disease. Even among insured patients, many people with ASCVD are prone to financial hardship because of the high cost of insurance, including deductibles, co-pays and co-insurances. However, there is a lack of data on the full impact of this financial burden.

“The costs of managing ASCVD are substantial and constitute a major source of concern at a personal level, especially for low-income families and uninsured patients who generally may not have enough financial reserves with which to offset the burden of unexpected health care expenditures,” said Khurram Nasir, M.D., MPH, MSc, senior author of the paper and director of population health and health systems research at Yale Center for Outcomes Research and Evaluation. “Our study highlights that a substantial proportion of non-elderly ASCVD patients and their families in the U.S. struggle with medical bills.”

Authors of this paper, led by Javier Valero-Elizondo, M.D., MPH, looked at data from the National Health Interview Survey from 2013-2017 to assess the national burden of financial hardship from medical bills among individuals with ASCVD; they also looked at potential consequences, including financial distress, food insecurity and cost-related medication non-adherence. They specifically looked at adults ages 18-64 with ASCVD to capture the patient population without universal financial protections from public insurance.

Of the 6,160 adults ages 18-64 with ASCVD in the survey, individuals were defined as having financial hardship from medical bills if they or anyone in their family reported having problems paying medical bills in the past year or were currently paying off medical bills over time. If they reported problems paying bills, they were then asked if they have bills they are unable to pay at all.

The study population was then divided into three categories:

  • “No financial hardship from medical bills”;
  • “Financial hardship from medical bills but able to pay”; and
  • “Unable to pay bills at all.”

Researchers found that 45.1 percent were part of families that reported having financial hardship from medical bills, and 18.9 percent reported being unable to pay their medical bills at all. Lower income and higher income individuals, as well as insured and uninsured, reported financial hardship and inability to pay; however, the highest burden of financial hardship and inability to pay was reported among uninsured and low-income individuals.

The authors also reported that nearly 1 in 3 ASCVD patients with financial hardship from their medical bills said they were suffering from financial distress, were cutting back on basic amenities such as food or were not taking needed medications as a result. One in 5 patients unable to pay medical bills reported all three situations.

“Our study underscores the fact that while insurance coverage is critical to protect against risk of financial burden from unexpected medical bills, current insurance structure falls short in protecting from financial hardship,” Nasir said. “The vast majority of individuals with ASVCD reporting problems paying bills and paying them over time are insured.”

Limitations of the study include that the construct used to define financial hardship from medical bills was based upon available data in the survey. Also, the question that asked not only about an individual but if anyone in the household had financial hardship from medical bills, precludes direct assessment of the proportion of medical bills related to ASCVD. However, a recent study found that healthcare spending on ASCVD patients represented a mean of 70 percent of overall family out of pocket healthcare spending.

For more information: www.onlinejacc.org

Reference

1. Valero-Elizondo J., Khera R., Saxena A., et al. Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology, Feb. 11, 2019. DOI: 10.1016/j.jacc.2018.12.004

Related Content

ACC Combines NCDR, Accreditation Into New Quality Summit
News | Cardiovascular Business | March 15, 2019
The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR...
Diagnostic and Interventional Cardiology Named 2019 Azbee Awards Finalist for Social Media
News | Cardiovascular Business | March 08, 2019 | Jeff Zagoudis, Associate Editor
Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019...
 FDA Commissioner Scott Gottlieb Announces Resignation
News | Cardiovascular Business | March 05, 2019 | Jeff Zagoudis, Associate Editor
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two...
Diagnostic and Interventional Cardiology Honored as Jesse H. Neal Awards Finalist

An example of the new transesophageal echo (TEE) visualization technology called TrueVue was shown at TCT 2018 for the first time. Philips’ new photo-realistic rendering is designed to offer a surgical view of cardiac structures to aid transcatheter procedural navigation.

News | Cardiovascular Business | February 25, 2019
Diagnostic and Interventional Cardiology has been recognized as a finalist in the Jesse H. Neal Awards for the third...
GE to Postpone Healthcare IPO Following Biopharmaceutical Business Sale
News | Cardiovascular Business | February 25, 2019 | Jeff Zagoudis, Associate Editor
GE Healthcare announced Feb. 25 the sale of its biopharmaceutical business to Danaher, and GE Chairman and CEO Larry...
Researchers raised the question whether an economic benefit should be assessed in FDA reviews. A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters.

A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews. 

Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S.
GE Submits Initial Public Offering Paperwork for Healthcare Division
News | Cardiovascular Business | December 19, 2018
As part of its plans to spin off its healthcare division into a separate company, GE reportedly submitted the paperwork...
Affordable Care Act Ruled Unconstitutional in Texas Federal Court
News | Cardiovascular Business | December 17, 2018
A judge of the Federal District Court for the Northern District of Texas ruled the Affordable Care Act (ACA)...
Average Age of U.S. Cardiologists Up While Income is Down
News | Cardiovascular Business | October 25, 2018
Overall cardiology compensation has dropped for the first time since 2014, according to the sixth annual Cardiovascular...
Overlay Init